Zum Inhalt
Erschienen in:

10.06.2021 | Reviews

Antirheumatic drugs in older adults and polypharmacy issues

verfasst von: Ilke Coskun Benlidayi, MD, Yesim Gokce Kutsal, MD

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Older individuals experience various noninflammatory and autoimmune inflammatory rheumatic diseases. Given the increased incidence of rheumatic conditions in older adults, it is of great importance for healthcare providers to be aware of the potential benefits and risks of antirheumatic drugs. The present article aims to provide a comprehensive review regarding antirheumatic drug use in older patients, particularly by focusing on safety issues and polypharmacy. Antirheumatic medications include nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and disease-modifying antirheumatic drugs (DMARDs), which comprise conventional synthetic DMARDs, targeted synthetic DMARDs and biological DMARDs. Due to the alteration in drug pharmacokinetics and pharmacodynamics in old people, antirheumatic drug efficiency and safety may be different than in the younger population. Polypharmacy and multimorbidity are other potential challenges to be faced during the treatment of older patients with rheumatic diseases. The current review also discusses the strategies to minimize adverse reactions due to antirheumatic drugs.
Literatur
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Metadaten
Titel
Antirheumatic drugs in older adults and polypharmacy issues
verfasst von
Ilke Coskun Benlidayi, MD
Yesim Gokce Kutsal, MD
Publikationsdatum
10.06.2021
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 6/2022
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-021-01907-6